Ftse Mib
33.220,31
0,00%
DAX
18.067,91
-0,31%
S&P 500
5.487,03
0,25%
NASDAQ
17.862,23
0,03%
Bitcoin
65.571,72
0,93%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE K V Pharma CL B (KVB) K V Pharma CL B (KVB) Notizie

KVB

K V Pharma CL B (KVB)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:KVB
DataOraFonteTitoloSimboloCompagnia
18/06/201215:04Dow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS to WATCHNYSE:KVBK V Pharma CL B
17/11/201102:15Business WireGlancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
03/11/201102:40Business WireLaw Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
01/11/201102:30Business WireGlancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
28/10/201122:30Business WireFaruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
24/10/201119:52Business WireThe Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
13/06/201114:00PR Newswire (US)K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference CallNYSE:KVBK V Pharma CL B
01/04/201121:08Dow Jones NewsUPDATE: K-V Pharma Slashes Price Of Preterm Labor Drug Amid OutcryNYSE:KVBK V Pharma CL B
01/04/201116:28Dow Jones NewsK-V Pharma Slashes Prices Of Preterm Labor Drug After FDA MoveNYSE:KVBK V Pharma CL B
31/03/201123:28Dow Jones NewsReligious Groups Urge Drug Makers To Ease Up On Price HikesNYSE:KVBK V Pharma CL B
30/03/201121:58Dow Jones NewsUPDATE: K-V Pharma Shares Drop On FDA Statement On Preterm Birth DrugNYSE:KVBK V Pharma CL B
30/03/201118:38Dow Jones NewsK-V Pharma Shares Drop On FDA Statement On Preterm Birth DrugNYSE:KVBK V Pharma CL B
01/03/201114:49PR Newswire (US)K-V Pharmaceutical Company Announces $200 Million Private Debt OfferingNYSE:KVBK V Pharma CL B
14/02/201116:34PR Newswire (US)K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to IssueNYSE:KVBK V Pharma CL B
14/02/201115:48PR Newswire (US)K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common StockNYSE:KVBK V Pharma CL B
04/02/201114:40PR Newswire (US)K-V Pharmaceutical Company to Host Investor Conference Call on February 14, 2011NYSE:KVBK V Pharma CL B
12/01/201115:03PR Newswire (US)K-V Pharmaceutical Company Updates Status of New Drug Application for Gestiva™NYSE:KVBK V Pharma CL B
14/09/201016:29Dow Jones NewsK-V Pharmaceutical Enters Loan Agreement In Wake Of FDA ApprovalNYSE:KVBK V Pharma CL B
10/09/201015:53Dow Jones NewsK-V Pharma Soars On FDA Approval To Return Product To MarketNYSE:KVBK V Pharma CL B
20/01/201021:41Dow Jones NewsUPDATE: Watson Pharma Benefits From Toprol Market PresenceNYSE:KVBK V Pharma CL B
20/01/201020:11Dow Jones NewsWatson Pharma Continues To Benefit From Toprol Market PresenceNYSE:KVBK V Pharma CL B
11/01/201015:18PR Newswire (US)KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)NYSE:KVB
07/01/201022:10PR Newswire (US)KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of DirectorNYSE:KVB
15/12/200923:26PR Newswire (US)KV Pharmaceutical Sets Record Date for Stockholder Action by Written ConsentNYSE:KVB
02/12/200922:45PR Newswire (US)KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van VlietNYSE:KVB
13/11/200922:01PR Newswire (US)KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw AmendmentsNYSE:KVB
07/10/200919:54Dow Jones NewsLarge Generic Drug Cos Benefiting From Price StabilityNYSE:KVBK-V Pharmaceutical Co. (Cl B)
21/09/200914:30PR Newswire (US)KV Pharmaceutical Divests ANDA for Generic Version of Duac(R)NYSE:KVB
15/09/200922:34PR Newswire (US)KV Pharmaceutical Receives Stockholder Action by Written ConsentNYSE:KVB
04/09/200923:43PR Newswire (US)KV Pharmaceutical Appoints Interim Chief Financial OfficerNYSE:KVB
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:KVB

La tua Cronologia

NASDAQI
HX101010GI
OMX Helsinki Software an...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network